Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Atibalentja is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2019 - 2022
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2016 - 2019
University of California San Francisco School of MedicineClass of 2016
Publications & Presentations
PubMed
- Targeting the MYC oncogene with a selective bi-steric mTORC1 inhibitor elicits tumor regression in MYC-driven cancers.Wadie D Mahauad-Fernandez, Yu Chi Yang, Ian Lai, Jangho Park, Lilian Yao
Cell Chemical Biology. 2025-08-21 - 3 citationsA big step for MYC-targeted therapies.Danielle F Atibalentja, Anja Deutzmann, Dean W Felsher
Trends in Cancer. 2024-05-01 - Expanding the Reach of Personalized Medicine in Cancer Care: Current Progress and Future Directions of.Yushu Shi, J Bryan Iorgulescu, Stephanie Valladao, Danielle F Atibalentja
JCO Precision Oncology. 2024-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
